secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2024-04-16T23:59:59+00:00
Accession:  0001193125-24-097776
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx appoints John W. Hanna as President and CEO effective April 15, 2024
---------------------------------------------------------------------------

- John Hanna appointed CEO and Class III director, effective April 15, 2024.
- Annual base salary of $675,000; eligible for annual bonus up to 100% of salary.
- Received inducement options and RSUs each valued at $4M, vesting over four years.
- Previously CEO of Apton Biosystems and CCO at Veracyte for ten years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000119312524097776/0001193125-24-097776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000119312524097776/d822701d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-097776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer